1. Brożek, JL, Bousquet, J, Agache, I, et al. Allergic rhinitis and its impact on asthma (ARIA) guidelines—2016 revision. J Allergy Clin Immunol. 2017;140(4):950–958. doi:10.1016/j.jaci.2017.03.050
Google Scholar | Crossref | Medline2. Bousquet, J, Khaltaev, N, Cruz, AA, et al. Allergic rhinitis and its impact on asthma (ARIA) 2008*. Allergy. 2008;63(s86):8–160. doi:10.1111/j.1398-9995.2007.01620.x
Google Scholar | Crossref | Medline3. Bousquet, J, Anto, JM, Bachert, C, et al. Allergic rhinitis. Nat Rev Dis Primers. 2020;6(1):95. doi:10.1038/s41572-020-00227-0
Google Scholar | Crossref | Medline4. Wallace, DV, Dykewicz, MS, Bernstein, DI, et al. The diagnosis and management of rhinitis: an updated practice parameter. J Allergy Clin Immunol. 2008;122(2 Supplement):S1–S84. doi:10.1016/j.jaci.2008.06.003
Google Scholar | Crossref | Medline5. Bousquet, J, Schünemann, HJ, Togias, A, et al. Next-generation allergic rhinitis and its impact on asthma (ARIA) guidelines for allergic rhinitis based on grading of recommendations assessment, development and evaluation (GRADE) and real-world evidence. J Allergy Clin Immunol. 2020;145(1):70–80.e3. doi:10.1016/j.jaci.2019.06.049
Google Scholar | Crossref | Medline6. Van Cauwenberge, P, Bachert, C, Passalacqua, G, et al. Consensus statement* on the treatment of allergic rhinitis. Allergy. 2000;55(2):116–134. doi:10.1034/j.1398-9995.2000.00526.x
Google Scholar | Crossref | Medline7. Mortuaire, G, Michel, J, Papon, JF, et al. Specific immunotherapy in allergic rhinitis. Eur Ann Otorhinolaryngol Head Neck Dis. 2017;134(4):253–258. doi:10.1016/j.anorl.2017.06.005
Google Scholar | Crossref | Medline8. Hossenbaccus, L, Linton, S, Garvey, S, Ellis, AK. Towards definitive management of allergic rhinitis: best use of new and established therapies. Allergy Asthma Clin Immunol. 2020;16(1):39. doi:10.1186/s13223-020-00436-y
Google Scholar | Crossref | Medline9. Bousquet, PJ, Combescure, C, Neukirch, F, et al. Visual analog scales can assess the severity of rhinitis graded according to ARIA guidelines. Allergy. 2007;62(4):367–372. doi:10.1111/j.1398-9995.2006.01276.x
Google Scholar | Crossref | Medline10. Juniper, EF, Guyatt, GH. Development and testing of a new measure of health status for clinical trials in rhinoconjunctivitis. Clin Exp Allergy. 1991;21(1):77–83. doi:10.1111/j.1365-2222.1991.tb00807.x
Google Scholar | Crossref | Medline11. Nathan, RA, Eccles, R, Howarth, PH, Steinsvåg, SK, Togias, A. Objective monitoring of nasal patency and nasal physiology in rhinitis. J Allergy Clin Immunol. 2005;115(3 Supplement):S442–S459. doi:10.1016/j.jaci.2004.12.015
Google Scholar | Crossref | Medline12. Martins de Oliveira, GM, Rizzo, JÂ, Camargos, PA, Sarinho, ES. Are measurements of peak nasal flow useful for evaluating nasal obstruction in patients with allergic rhinitis? Rhinology. 2015;53(2):160–166. doi:10.4193/Rhin14.048
Google Scholar | Crossref | Medline13. Wilson, DR, Torres Lima, M, Durham, SR. Sublingual immunotherapy for allergic rhinitis: systematic review and meta-analysis*. Allergy. 2005;60(1):4–12. doi:10.1111/j.1398-9995.2005.00699.x
Google Scholar | Crossref | Medline14. Weiner, JM, Abramson, MJ, Puy, RM. Intranasal corticosteroids versus oral H1 receptor antagonists in allergic rhinitis: systematic review of randomised controlled trials. Br Med J. 1998;317(7173):1624. doi:10.1136/bmj.317.7173.1624
Google Scholar | Crossref | Medline15. Nurmatov, U, Dhami, S, Arasi, S, et al. Allergen immunotherapy for allergic rhinoconjunctivitis: a systematic review and meta-analysis. Allergy. 2017;72(11):1597–1631. doi:10.1111/all.13201
Google Scholar | Crossref | Medline16. Liberati, A, Altman, DG, Tetzlaff, J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. PLoS Med 6(7): e1000100. 2009:1756–1833.
Google Scholar | Crossref | Medline17. Kim, JH, Lee, JH, Ye, YM, et al. Efficacy and safety of sublingual immunotherapy in elderly rhinitis patients sensitized to house dust mites. Allergy Asthma Immunol Res. 2018;10(6):675–685. doi:10.4168/aair.2018.10.6.675
Google Scholar | Crossref | Medline18. Locks, RB, Dos Santos, K, da Silva, J. Quality of life in patients with allergic rhinitis: a clinical trial comparing the use of bilastine versus loratadine. Clin Otolaryngol. 2017;42(2):218–224. doi:10.1111/coa.12695
Google Scholar | Crossref | Medline19. Ellis, AK, Soliman, M, Steacy, L, et al. The allergic rhinitis - clinical investigator collaborative (AR-CIC): nasal allergen challenge protocol optimization for studying AR pathophysiology and evaluating novel therapies. Allergy Asthma Clin Immunol. 2015;11(1):16–16. doi:10.1186/s13223-015-0082-0
Google Scholar | Crossref | Medline20. Meltzer, EO, Wallace, D, Dykewicz, M, Shneyer, L. Minimal clinically important difference (MCID) in allergic rhinitis: agency for healthcare research and quality or anchor-based thresholds? J Allergy Clin Immunol Pract. 2016;4(4):682–688. doi:10.1016/j.jaip.2016.02.006
Google Scholar | Crossref | Medline21. Juniper, EF, Guyatt, GH, Griffith, LE, Ferrie, PJ. Interpretation of rhinoconjunctivitis quality of life questionnaire data. J Allergy Clin Immunol. 1996;98(4):843–845. doi:10.1016/S0091-6749(96)70135-5
Google Scholar | Crossref | Medline22. Chin D, MG, Malek, J, Pratt, E, Sacks, R, Snidvongs, K, Harvey, R. Nasal peak inspiratory flow (NPIF) as a diagnostic tool for differentiating decongestable from structural nasal obstruction. Rhinology. 2014;52(2):116–121. doi:10.4193/Rhin13.126
Google Scholar | Crossref | Medline23. Timperley, DSA, Stow, N, Marcells, GN, Harvey, RJ. Minimal clinically important differences in nasal peak inspiratory flow. Rhinology. 2011;49(1):37–40. doi:10.4193/Rhino10.097
Google Scholar | Crossref | Medline24. Oxford . OCEBM levels of evidence. University of Oxford. Accessed December 11, 2020. https://www.cebm.ox.ac.uk/resources/levels-of-evidence/ocebm-levels-of-evidence.
Google Scholar25. Higgins, JP, Thomas, J, Chandler, J, Cumpston, M, Li, T, Page, MJ, Welch, VA (eds). Cochrane handbook for systematic reviews of interventions version 6.1. Cochrane; updated September 2020. www.training.cochrane.org/handbook
Google Scholar26. Borenstein, M, Hedges, LV, Higgins, JPT, Rothstein, HR. An introduction to meta-analysis. In: Introduction to meta-analysis. John Wiley & Sons, Ltd; 2009:1–49.
Google Scholar | Crossref27. DerSimonian, R, Laird, N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177–188.
Google Scholar | Crossref | Medline28. Egger, M, Smith, GD, Schneider, M, Minder, C. Bias in meta-analysis detected by a simple, graphical test. Br Med J. 1997;315(7109):629–634.
Google Scholar | Crossref | Medline29. Sterne, JA, Egger, M. Funnel plots for detecting bias in meta-analysis: guidelines on choice of axis. J Clin Epidemiol. 2001 Oct;54(10):1046–1055.
Google Scholar | Crossref | Medline30. Lee, DK, Gray, RD, Robb, FM, Fujihara, S, Lipworth, BJ. A placebo-controlled evaluation of butterbur and fexofenadine on objective and subjective outcomes in perennial allergic rhinitis. Clin Exp Allergy. 2004;34(4):646–649. doi:10.1111/j.1365-2222.2004.1903.x
Google Scholar | Crossref | Medline31. Guilemany, JM, Garcia-Pinero, A, Alobid, I, et al. The loss of smell in persistent allergic rhinitis is improved by levocetirizine due to reduction of nasal inflammation but not nasal congestion (the CIRANO study). Int Arch Allergy Immunol. 2012;158(2):184–190. doi:10.1159/000331329
Google Scholar | Crossref | Medline32. Caruso, M, Cibella, F, Emma, R, et al. Basophil biomarkers as useful predictors for sublingual immunotherapy in allergic rhinitis. Int Immunopharmacol. 2018 Jul;60(1):50–58. doi:10.1016/j.intimp.2018.04.034
Google Scholar | Crossref | Medline33. Revicki, D, Hays, RD, Cella, D, Sloan, J. Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes. J Clin Epidemiol. 2008;61(2):102–109. doi:10.1016/j.jclinepi.2007.03.012
Google Scholar | Crossref | Medline34. Seresirikachorn, K, Mullol, J, Limitlaohaphan, K, Asvapoositkul, V, Snidvongs, K. Leukotriene receptor antagonist addition to intranasal steroid: systematic review and meta-analysis. Rhinology. 2021;59(1):2–9.
Google Scholar | Crossref | Medline35. Feng, S, Fan, Y, Liang, Z, Ma, R, Cao, W. Concomitant corticosteroid nasal spray plus antihistamine (oral or local spray) for the symptomatic management of allergic rhinitis. Eur Arch Oto-Rhino-Laryngol. 2016;273(11):3477–3486. doi:10.1007/s00405-015-3832-1
Google Scholar | Crossref | Medline36. Du, K, Qing, H, Zheng, M, Wang, X, Zhang, L. Intranasal antihistamine is superior to oral H1 antihistamine as an add-on therapy to intranasal corticosteroid for treating allergic rhinitis. Ann Allergy Asthma Immunol. 2020;125(5):589–596.e3. doi:10.1016/j.anai.2020.06.038
Google Scholar | Crossref | Medline37. Barnes, ML, Vaidyanathan, S, Williamson, PA, Lipworth, BJ. The minimal clinically important difference in allergic rhinitis. Clin Exp Allergy. 2010;40(2):242–250. doi:10.1111/j.1365-2222.2009.03381.x
Google Scholar | Crossref | Medline38. Klimek, L, Bachert, C, Pfaar, O, et al. ARIA Guideline 2019: treatment of allergic rhinitis in the German health system. Allergol Select. 2019;3(1):22–50.
Google Scholar | Crossref | Medline39. Mygind, N, Nielsen, LP, Hoffmann, H-J, et al. Mode of action of intranasal corticosteroids. J Allergy Clin Immunol. 2001;108(1 Supplement):S16–S25. doi:10.1067/mai.2001.115561
Google Scholar | Crossref | Medline40. Achilles, N, Pasch, N, Lintermann, A, Schröder, W, Mösges, R. Computational fluid dynamics: a suitable assessment tool for demonstrating the antiobstructive effect of drugs in the therapy of allergic rhinitis. Acta Otorhinolaryngol Ital. 2013;33(1):36–42.
Google Scholar | Medline41. Juel-Berg, N, Darling, P, Bolvig, J, et al. Intranasal corticosteroids compared with oral antihistamines in allergic rhinitis: a systematic review and meta-analysis. Am J Rhinol Allergy. 2017;31(1):19–28. doi:10.2500/ajra.2016.30.4397
Google Scholar | SAGE Journals42. Nielsen, LP, Dahl, R. Comparison of intranasal corticosteroids and antihistamines in allergic rhinitis: a review of randomized, controlled trials. Am J Respir Med. 2003;2(1):55–65. doi:10.1007/BF03256639
Google Scholar | Crossref | Medline43. Meltzer, EO, Caballero, F, Fromer, LM, Krouse, JH, Scadding, G. Treatment of congestion in upper respiratory diseases. Int J Gen Med. 2010;3(1)69–91.
Google Scholar | Crossref | Medline44. Crown, WH, Olufade, A, Smith, MW, Nathan, R. Seasonal versus perennial allergic rhinitis: drug and medical resource use patterns. Value Health. 2003;6(4):448–456. doi:10.1046/j.1524-4733.2003.64231.x
Google Scholar | Crossref | Medline45. Wallace, DV, Dykewicz, MS, Oppenheimer, J, Portnoy, JM, Lang, DM. Pharmacologic treatment of seasonal allergic rhinitis: synopsis of guidance from the 2017 joint task force on practice parameters. Ann Intern Med. 2017;167(12):876–881. doi:10.7326/M17-2203
Google Scholar | Crossref |